Used primarily in peptide synthesis as a chiral building block, this compound serves as a protected pyrrolidine derivative that enables stereoselective construction of complex molecules. Its Fmoc group allows for mild base-labile protection, making it compatible with solid-phase peptide synthesis (SPPS). The methyl-substituted pyrrolidine core introduces conformational constraints, which are valuable in designing peptidomimetics and bioactive compounds with improved metabolic stability and receptor selectivity. Commonly employed in pharmaceutical research, especially in the development of protease inhibitors and central nervous system agents.